hrcak mascot   Srce   HID

Uvodnik
https://doi.org/10.5599/admet.4.2.348

ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors

Godefridus Peters   ORCID icon orcid.org/0000-0002-5447-2877 ; Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands.
Kin Tam ; Faculty of Health Sciences, University of Macau, Taipa, Macau

Puni tekst: engleski, pdf (433 KB) str. 182-185 preuzimanja: 340* citiraj
APA 6th Edition
Peters, G. i Tam, K. (2016). ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors. ADMET and DMPK, 4 (3), 182-185. https://doi.org/10.5599/admet.4.2.348
MLA 8th Edition
Peters, Godefridus i Kin Tam. "ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors." ADMET and DMPK, vol. 4, br. 3, 2016, str. 182-185. https://doi.org/10.5599/admet.4.2.348. Citirano 27.10.2021.
Chicago 17th Edition
Peters, Godefridus i Kin Tam. "ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors." ADMET and DMPK 4, br. 3 (2016): 182-185. https://doi.org/10.5599/admet.4.2.348
Harvard
Peters, G., i Tam, K. (2016). 'ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors', ADMET and DMPK, 4(3), str. 182-185. https://doi.org/10.5599/admet.4.2.348
Vancouver
Peters G, Tam K. ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors. ADMET and DMPK [Internet]. 2016 [pristupljeno 27.10.2021.];4(3):182-185. https://doi.org/10.5599/admet.4.2.348
IEEE
G. Peters i K. Tam, "ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors", ADMET and DMPK, vol.4, br. 3, str. 182-185, 2016. [Online]. https://doi.org/10.5599/admet.4.2.348

Sažetak
Editorial

Ključne riječi
ADME; DMPK; tyrosine kinase, serine-threonine kinase

Hrčak ID: 167041

URI
https://hrcak.srce.hr/167041

Posjeta: 545 *